Natera, Inc. - Common Stock (NQ:NTRA)

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Natera (NASDAQ:NTRA) and its peers.

A Glimpse Into The Expert Outlook On Natera Through 8 Analysts

October 23, 2025

Via Benzinga

Reflecting On Immuno-Oncology Stocks’ Q2 Earnings: Natera (NASDAQ:NTRA)

October 20, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 7.2% in the afternoon session after the company announced promising results from its phase 3 IMvigor011 clinical trial for its Signatera...

Topics Artificial Intelligence

Why Are Natera (NTRA) Shares Soaring Today

October 20, 2025

Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients

Topics Intellectual Property

How Do Investors Really Feel About Natera?

September 23, 2025

Via Benzinga

October 20, 2025

Natera Named to Fast Company’s Next Big Things in Tech List

October 16, 2025

Here's How Much $1000 Invested In Natera 5 Years Ago Would Be Worth Today

October 13, 2025

Via Benzinga

Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings

October 13, 2025

Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium

October 12, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 That Underwhelm

October 06, 2025

Topics Retirement

Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT

October 01, 2025

Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer

September 30, 2025

Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows

September 29, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

2 Safe-and-Steady Stocks to Target This Week and 1 Facing Headwinds

September 29, 2025

Stocks making big moves yesterday: Acadia Healthcare, Tesla, THOR Industries, Natera, and P10

September 25, 2025

Check out the companies making headlines yesterday:

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 4.5% in the afternoon session after Wells Fargo & Company initiated coverage on the stock with a neutral "equal weight" rating and set a...

Topics Electric Vehicles

Here's How Much $1000 Invested In Natera 5 Years Ago Would Be Worth Today

September 24, 2025

Via Benzinga

Why Natera (NTRA) Stock Is Down Today

September 24, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Topics Artificial Intelligence Lawsuit

Deep Dive Into Natera Stock: Analyst Perspectives (6 Ratings)

September 22, 2025

Via Benzinga

If You Invested $100 In Natera Stock 5 Years Ago, You Would Have This Much Today

September 15, 2025

Via Benzinga

2 Unprofitable Stocks on Our Watchlist and 1 We Ignore

September 15, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 2.7% in the afternoon session after the company reached an $8.25 million settlement in a legal case. The case, titled 'Amanda Davis v....

Why Natera (NTRA) Stock Is Trading Lower Today

September 12, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 4.1% in the afternoon session after a key competitor, Exact Sciences, announced the launch of a new multi-cancer early detection blood...

Topics Artificial Intelligence Lawsuit

Why Natera (NTRA) Shares Are Falling Today

September 10, 2025

Since September 2020, the S&P 500 has delivered a total return of 94.8%. But one standout stock has doubled the market - over the past five years, Natera has surged 186% to $176.64 per share. Its...

Topics Intellectual Property

3 Reasons We’re Fans of Natera (NTRA)

September 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Topics Stocks

1 Cash-Producing Stock to Own for Decades and 2 We Find Risky

September 01, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). fell 0.9% in the morning session after the company announced an unfavorable court ruling in its ongoing patent litigation with competitor...

Topics Supply Chain

Why Natera (NTRA) Stock Is Down Today

August 29, 2025

NeoGenomics wins a North Carolina court ruling invalidating key Natera patents, clearing the way for its RaDaR ST assay and boosting investor sentiment.

Topics Intellectual Property

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

August 29, 2025

Via Benzinga

Topics Intellectual Property

Natera Provides Update on Patent Litigation with NeoGenomics

August 29, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 3% in the afternoon session after the company announced its Signatera molecular residual disease test was selected for a Phase III...

12 Health Care Stocks Moving In Friday's Pre-Market Session

August 29, 2025

Via Benzinga

Why Natera (NTRA) Stock Is Up Today

August 28, 2025